Product Information
AMITRIPTYLINE HCL 10 MG TAB is a generic product labeled by Accord Healthcare Inc., priced at $0.0320 per EA under NDC 16729017101. Its NADAC has been published 589 times since Feb 11, 2015.
FDA first approved this application on Jun 4, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the AMITRIPTYLINE HYDROCHLORIDE market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
10 mg/1
Manufacturer
Accord Healthcare Inc.NDC
16729017101
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
5/20/2026
Active Ingredients
AMITRIPTYLINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA202446FDA Approved
6/4/2014
TE Code
AB
On Market Since
12/5/2014
Pharmacological Classes
Price Statistics
The NADAC for AMITRIPTYLINE HCL 10 MG TAB has been published 589 times since Feb 11, 2015, and over the history we have for it it has declined 75.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0320 per EA |
|---|---|
| All-time high | $0.1311 (Feb 11, 2015) |
| All-time low | $0.0285 (Nov 20, 2024) |
| 52-week high | $0.0375 |
| 52-week low | $0.0320 |
| Median price | $0.0628 |
| Average price | $0.0734 |
| Largest weekly change | +30.2% (Jun 19, 2024) |
| Weeks tracked | 589 |
| Tracking since | Feb 11, 2015 |
1W
N/A
1M
N/A
3M
N/A
6M
-6.3%
1Y
-13.9%
3Y
-22.4%
5Y
-43.5%
All
-75.6%
Last surveyed May 20, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of AMITRIPTYLINE HCL 10 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for AMITRIPTYLINE HCL 10 MG TAB, manufactured by Accord Healthcare Inc., is $0.0320 per EA (NDC 16729017101), effective May 20, 2026.
How has the price of AMITRIPTYLINE HCL 10 MG TAB changed over time?
Over the history we have for it, the NADAC for AMITRIPTYLINE HCL 10 MG TAB has declined 75.6%. It has been tracked across 589 weekly CMS publications since Feb 11, 2015.
What are the highest and lowest recorded NADAC prices for AMITRIPTYLINE HCL 10 MG TAB?
Since Feb 11, 2015, the NADAC for AMITRIPTYLINE HCL 10 MG TAB has ranged from a low of $0.0285 (Nov 20, 2024) to a high of $0.1311 (Feb 11, 2015), with a median of $0.0628 per EA.
Are there cheaper alternatives to AMITRIPTYLINE HCL 10 MG TAB?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as AMITRIPTYLINE HCL 10 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures AMITRIPTYLINE HCL 10 MG TAB?
AMITRIPTYLINE HCL 10 MG TAB (NDC 16729017101) is labeled by Accord Healthcare Inc., and CMS classifies it as a generic product.